Here are nine key points:
1. Xtant’s quarterly revenues hit $21 million, a 3 percent decrease from the same period in 2015.
2. The company’s core recurring revenue rose to $20.5 million, a 6.8 percent increase from $19.2 million in the same period a year prior.
3. Xtant’s gross profit increased to $14.1 million.
4. Gross margins increased to 67.2 percent, compared to pro forma 63.4 percent in the first quarter of 2015.
5. Xtant experienced consolidated EBITDA loss of $145,000 for the first quarter of 2016.
6. The company saw a consolidated net loss of $5.6 million, compared to $6 million in quarter one 2015.
7. Sales and marketing expenses increased to $10.5 million from $9.6 billion the same quarter last year.
8. General and administrative expenses decreased to $3.5 million from $3.9 million in quarter one 2015.
9. Cash on hand hit $4.7 million by March 31, 2016.
More articles on devices:
FDA clears First Ray’s Stealth Staple System — 5 highlights
Medtronic names Karen Parkhill EVP, CFO: 5 key notes
Siemens, Ziehm, GE, Hologic, OrthoScan & Medtronic: 26 O-arm & C-arm systems
